Criticism of the Fourth Law on the amendment of the German Pharmaceuticals Act
The presentation of the outlined objections against the Fourth Law is based on a critical acclaim of jurist Scarlett Jansen. They critically acclaimed the previous draft bill of the Fourth Law:
Jansen, S. (2016). Der Schutz der Patienten und Probanden bei klinischen Prüfungen nach den geplanten Neuerungen im Arzneimittelrecht. Medizinrecht, 34(6), 417-423. https://doi.org/10.1007/s00350-016-4298-x